Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboplatin/Gemcitabine in Elderly Stage IV NSCLC
NCT02175381Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Feb 2011
- Primary completion
- Apr 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Feb 2011; status: completed.
02
Drugs
carboplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02175381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02175381.